Featured Market Report: Type 2 Diabetes – Epidemiology Forecast to 2024
November 16, 2015Manufacturing and Production, Research and Development diabetes, market reports
Diabetes is one of the most common non-communicable diseases worldwide and is an escalating public health problem globally, with an …
Pharma boss in sexism storm
November 16, 2015Immuno Biotech CEO David Noakes has been found guilty of sexual discrimination after making notes on the job application of …
FDA approves Baxalta Haemophilia A treatment
November 16, 2015Manufacturing and Production, Research and Development, Sales and Marketing
The US FDA has approved Baxalta’s twice-weekly therapy Adynovate for use in adults and adolescents, aged 12 years plus, with …
Former Health Secretary Andrew Lansley takes on Roche advisory role
November 16, 2015Medical Communications, Sales and Marketing
Former UK health secretary Andrew Lansley has taken on work as an advisor to Roche in the midst of ongoing …
Novo Nordisk invests $20m in diabetes research following study
November 16, 2015Research and Development, Sales and Marketing
Novo Nordisk has unveiled plans to combat urban diabetes in a $20 million investment offering expert resources and research funds …
Amgen’s Humira biosimilar succeeds in Phase III arthritis study
November 16, 2015Research and Development, Sales and Marketing Amgen, Humira
Amgen says its Humira (adalimumab) biosimilar candidate ABP 501 proved its clinical equivalence to Abbvie’s blockbuster drug in a head-to-head …
Takeda UK strengthens its senior leadership team
November 16, 2015Medical Communications, Sales and Marketing
Takeda UK is bolstering its Medical and Human Resources functions as Takeda continues to develop its expertise in the Specialty …
AstraZeneca earns ‘speedy’ FDA approval for lung cancer drug
November 13, 2015AZD9291, AstraZeneca, Tagrisso, lung cancer
The FDA has approved AstraZeneca’s new lung cancer drug Tagrisso, in a record two and half years from development, under …
Perrigo rejects $26 billion hostile Mylan takeover bid
November 13, 2015Medical Communications, Sales and Marketing Mylan, Perrigo, mergers and acquisitions
Perrigo has rejected Mylan’s hostile $26 billion bid after a 60% majority of shareholders were unconvinced by the terms by …
FDA expands Gilead’s Harvoni indications for Hep C
November 13, 2015Sales and Marketing Gilead, Gilead Sciences, harvoni, ledipasvir-sofosbuvir
Gilead’s Harvoni has been approved by the FDA for expanded use in patients with genotypes 4, 5 and 6 chronic …
New appointments for AstraZeneca’s Mene Pangalos
November 13, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Dr Mene Pangalos, executive vice president of the IMED Biotech Unit at AstraZeneca UK, has accepted two prestigious appointments that …
Google and AHA to fund $50m cardiovascular disease project
November 13, 2015Medical Communications, Research and Development American Heart Association, cardiovascular disease, google, heart disease
The American Heart Association and Google Life Sciences have announced a joint research collaboration to bring ‘unconventional thinking’ to the …
Patents prompting ‘rebirth’ of innovation in industry
November 13, 2015Medical Communications innovation, patents, pharma
Seven pharma companies have been rated among the world’s 100 most innovative companies, according to Thomson Reuters.The business intelligence firm …
Roche manufacturing restructure means EU, US jobs cuts
November 13, 2015Manufacturing and Production, Medical Communications Roche, job cuts, job losses, manufacturing, production, redundancies, restructure
Roche has announced plans to restructure its manufacturing network for small molecules, in a move that will see it mothball …
Boehringer cuts R&D budget to €11bn to focus on collaborations
November 13, 2015Medical Communications, Research and Development Boehringer Ingelheim
Boehringer Ingelheim has launched its new research and development strategy, committing €11 billion to R&D over the next five years. …
The ‘Pharmasaurus’ aims to evolve into a leader in the digital age
November 12, 2015Medical Communications, Research and Development Bayer, Roche, digital health, pharma
Pharma’s new-found willingness to embrace all aspects of the digital age, and use it both to its advantage and that …
Antibiotic prescriptions falling across England, but higher in deprived areas
November 12, 2015Medical Communications Antibiotics, prescribing
New data reveals that while antibiotic prescriptions have fallen across England in the last three years, struggling GP practices in …
Three new drugs approved for use in Scotland
November 12, 2015Sales and Marketing Scottish Medicines Consortium
The Scottish Medicines Consortium (SMC) has given the go-ahead for the use of several drugs on the NHS in Scotland. …
GSK ready for lupus drug push
November 12, 2015Manufacturing and Production, Research and Development, Sales and Marketing Benlysta, GSK, Lupus, SLE, belimumab, systemic lupus erythematosus
Having presented positive late-stage results for a new formulation of its inflammatory drug Benlysta, GSK says it will file supplementary …
Merck achieves 7% sales growth in Q3 2015
November 12, 2015Sales and Marketing Merck, Rebif, financial results
German pharma group Merck has earned a 7% bump in its sales, and a 10% boost in earnings before deductions, …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
